Disparities in gynecological malignancies

Frontiers in Oncology

Volumn 6, Issue FEB, 2016, Pages

  Chatterjee, Sudeshna ^a   Gupta, Divya ^a   Caputo, Thomas A ^a   Holcomb, Kevin ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Barriers to health; Gynecologic malignancies; Heath disparities; Race; Socioeconomic factors

Indexed keywords

BIOLOGICAL FACTOR;

CANCER SURVIVAL; ENDOMETRIUM CANCER; GEOGRAPHIC DISTRIBUTION; HEALTH DISPARITY; HEALTH INSURANCE; HOSPITAL; HUMAN; OVARY CANCER; RACE; RESEARCH; REVIEW; SOCIOECONOMICS; UNITED STATES; UTERINE CERVIX CANCER;

EID: 84964475935     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2016.00036     Document Type: Review

References (88)

1. Smedley BD, Stith AY, Nelson AR, editors. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health care. Vol. 20, Washington, DC: National Academies Press. (2003) 191 p
2. National Cancer Institute. Fact Sheet on Cancer Health Disparities (2007). Available from: http://www.cancer.gov/about-nci/organization/crchd/cancer-health-disparities-fact-sheet
3. Goss E, Lopez AM, Brown CL, Wollins DS, Brawley OW, Raghavan D. American society of clinical oncology policy statement: disparities in cancer care. J Clin Oncol (2009) 27:2881-5. doi: 10.1200/JCO.2008.21.1680
4. Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH. Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol (2014) 133:353-61. doi:10.1016/j.ygyno.2013.12.039
5. Morris AM, Rhoads KF, Stain SC, Birkmeyer JD. Understanding racial disparities in cancer treatment and outcomes. J Am Coll Surg (2010) 211:105-13. doi:10.1016/j.jamcollsurg.2010.02.051
6. Bristow RE, Chang J, Ziogas A, Anton-Culver H. Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol (2013) 121:1226-34. doi:10.1097/AOG.0b013e3182922a17
7. Cliby WA, Powell MA, Al-Hammadi N, Chen L, Philip Miller J, Roland PY, et al. Ovarian cancer in the United States: contemporary patterns of care associated with improved survival. Gynecol Oncol (2015) 136:11-7. doi:10.1016/j.ygyno.2014.10.023
8. Bristow RE, Zahurak ML, Diaz-Montes TP, Giuntoli RL, Armstrong DK. Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes. Gynecol Oncol (2009) 115:334-8. doi:10.1016/j.ygyno.2009.08.025
9. Bristow RE, Chang J, Ziogas A, Randall LM, Anton-Culver H. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease. Gynecol Oncol (2014) 132:403-10. doi:10.1016/j.ygyno.2013.12.017
10. GoffBA, Matthews BJ, Wynn M, Muntz HG, Lishner DM, Baldwin L-M. Ovarian cancer: patterns of surgical care across the United States. Gynecol Oncol (2006) 103:383-90. doi:10.1016/j.ygyno.2006.08.010
11. Fairfield KM, Lucas FL, Earle CC, Small L, Trimble EL, Warren JL. Regional variation in cancer-directed surgery and mortality among women with epithelial ovarian cancer in the medicare population. Cancer (2010) 116:4840-8. doi:10.1002/cncr.25242
12. Polsky D, Armstrong KA, Randall TC, Ross RN, Even-Shoshan O, Rosenbaum PR, et al. Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography. Health Serv Res (2006) 41:2201-18. doi:10.1111/j.1475-6773.2006.00596.x
13. Shalowitz DI, Vinograd AM, Giuntoli RL. Geographic access to gynecologic cancer care in the United States. Gynecol Oncol (2015) 139:206. doi:10.1016/j.ygyno.2015.07.089
14. GoffBA, Matthews BJ, Larson EH, Andrilla CHA, Wynn M, Lishner DM, et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer (2007) 109:2031-42. doi:10.1002/cncr.22604
15. Earle CC, Schrag D, Neville BA, YabroffKR, Topor M, Fahey A, et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst (2006) 98:172-80. doi:10.1093/jnci/djj019
16. Reade C, Elit L. Trends in gynecologic cancer care in North America. Obstet Gynecol Clin North Am (2012) 39:107-29. doi:10.1016/j.ogc.2012.02.003
17. Vernooij F, Heintz P, Witteveen E, van der Graaf Y. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol (2007) 105:801-12. doi:10.1016/j.ygyno.2007.02.030
18. Tan W, Stehman FB, Carter RL. Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979-2001. Gynecol Oncol (2009) 114:346-52. doi:10.1016/j.ygyno.2009.03.033
19. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA (2004) 291:2720-6. doi:10.1001/jama.291.22.2720
20. Scalici J, Finan MA, Black J, Harmon MD, Nicolson W, Lankes HA, et al. Minority participation in Gynecologic Oncology Group (GOG) Studies. Gynecol Oncol (2015) 138:441-4. doi:10.1016/j.ygyno.2015.05.014
21. Durant RW, Wenzel JA, Scarinci IC, Paterniti DA, Fouad MN, Hurd TC, et al. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT). Cancer (2014) 120(Suppl 7):1097-105. doi:10.1002/cncr.28574
22. Killien M, Bigby JA, Champion V, Fernandez-Repollet E, Jackson RD, Kagawa-Singer M, et al. Involving minority and underrepresented women in clinical trials: the national centers of excellence in women's health. J Womens Health Gend Based Med (2000) 9:1061-70. doi:10.1089/152460900445974
23. Kressin NR, Meterko M, Wilson NJ. Racial disparities in participation in biomedical research. J Natl Med Assoc (2000) 92:62-9
24. Mouton CP, Harris S, Rovi S, Solorzano P, Johnson MS. Barriers to black women's participation in cancer clinical trials. J Natl Med Assoc (1997) 89:721-7
25. Wendler D, Kington R, Madans J, Van Wye G, Christ-Schmidt H, Pratt LA, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med (2006) 3:e19. doi:10.1371/journal.pmed.0030019
26. Brooks SE, Muller CY, Robinson W, Walker EM, Yeager K, Cook ED, et al. Increasing minority enrollment onto clinical trials: practical strategies and challenges emerge from the NRG oncology accrual workshop. J Oncol Pract (2015) 11(6):486-90. doi:10.1200/JOP.2015.005934
27. Harlan LC, Greene AL, Clegg LX, Mooney M, Stevens JL, Brown ML. Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol (2005) 23:9079-88. doi:10.1200/JCO.2004.00.1297
28. DeNavas-Walt C, Proctor BD. Income and Poverty in the United States: 2014. United States Census Bureau (2015). Available from: https://www.census.gov/content/dam/Census/library/publications/2015/demo/p60-252.pdf
29. DeNavas-Walt C, Proctor BD, Smith JC. Income and Poverty in the United States: 2013. Washington, DC: United States Census Bureau (2014)
30. Smith JC, Medalia C. Health Insurance Coverage in the United States: 2014. United States Census Bureau (2015). Available from: http://www.census.gov/content/dam/Census/library/publications/2015/demo/p60-253.pdf
31. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin (2015) 65:5-29. doi:10.3322/caac.21314
32. Bristow RE, Chang J, Ziogas A, Campos B, Chavez LR, Anton-Culver H. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines. Obstet Gynecol (2015) 125:833-42. doi:10.1097/AOG.0000000000000643
33. Esselen KM, Vitonis A, Einarsson J, Muto MG, Cohen S. Health care disparities in hysterectomy for gynecologic cancers: data from the 2012 national inpatient sample. Obstet Gynecol (2015) 126:1029-39. doi:10.1097/AOG.0000000000001088
34. Harlan LC, Clegg LX, Trimble EL. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol (2003) 21:3488-94. doi:10.1200/JCO.2003.01.061
35. Bristow RE, Powell MA, Al-Hammadi N, Chen L, Miller JP, Roland PY, et al. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst (2013) 105:823-32. doi:10.1093/jnci/djt065
36. Long B, Chang J, Ziogas A, Tewari KS, Anton-Culver H, Bristow RE. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California. Am J Obstet Gynecol (2015) 212:.e1-9. doi:10.1016/j.ajog.2014.10.1104
37. Hodeib M, Chang J, Liu F, Ziogas A, Dilley S, Randall LM, et al. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer. Gynecol Oncol (2015) 138:121-7. doi:10.1016/j.ygyno.2015.04.011
38. Chan JK, Zhang M, Hu JM, Shin JY, Osann K, Kapp DS. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States. J Surg Oncol (2008) 97:103-7. doi:10.1002/jso.20932
39. Fairfield KM, Murray KM, Wierman HR, Han PKJ, Hallen S, Miesfeldt S, et al. Disparities in hospice care among older women dying with ovarian cancer. Gynecol Oncol (2012) 125:14-8. doi:10.1016/j.ygyno.2011.11.041
40. DeSantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin (2013) 63:151-66. doi:10.3322/caac.21173
41. American Cancer Society. Cancer Facts & Figures for Hispancs/Latinos 2012-2014. Atlanta, GA: American Cancer Society (2012). Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-034778.pdf
42. Miller BA, Chu KC, Hankey BF, Ries LAG. Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes Control (2008) 19:227-56. doi:10.1007/s10552-007-9088-3
43. Gomez SL, Noone A-M, Lichtensztajn DY, Scoppa S, Gibson JT, Liu L, et al. Cancer incidence trends among Asian American populations in the United States, 1990-2008. J Natl Cancer Inst (2013) 105:1096-110. doi:10.1093/jnci/djt157
44. Trinh Q-D, Nguyen PL, Leow JJ, Dalela D, Chao GF, Mahal BA, et al. Cancer-specific mortality of Asian Americans diagnosed with cancer: a nationwide population-based assessment. J Natl Cancer Inst (2015) 107:djv054. doi:10.1093/jnci/djv054
45. Harper S, Lynch JW. Methods for Measuring Cancer Disparities: Using Data Relevant to Healthy People 2010 Cancer-Related Objectives. Bethesda, MD: National Cancer Institute (2005)
46. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute (2011). 19 p
47. Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, et al. Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst (2015) 107:djv048. doi:10.1093/jnci/djv048
48. Parham G, Phillips JL, Hicks ML, Andrews N, Jones WB, Shingleton HM, et al. The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women. Cancer (1997) 80:816-26. doi:10.1002/(SICI)1097-0142(19970815)80:4<816::AID-CNCR21>3.3.CO;2-W
49. Morris CR, Sands MT, Smith LH. Ovarian cancer: predictors of early-stage diagnosis. Cancer Causes Control (2010) 21:1203-11. doi:10.1007/s10552-010-9547-0
50. National Cancer Institute. SEER Stat Fact Sheets: Ovary Cancer. (2015). Available from: http://seer.cancer.gov/statfacts/html/ovary.html
51. Chow EA, Foster H, Gonzalez V, McIver L. The disparate impact of diabetes on racial/ethnic minority populations. Clin Diabetes (2012) 30:130-3. doi:10.2337/diaclin.30.3.130
52. Opara F, Hawkins K, Sundaram A, Merchant M, Rasmussen S, Holmes L. Impact of comorbidities on racial/ethnic disparities in hypertension in the United States. Int Sch Res Notices (2013) 2013:1-8. doi:10.1155/2013/967518
53. Howell EA, Egorova N, Hayes MP, Wisnivesky J, Franco R, Bickell N. Racial disparities in the treatment of advanced epithelial ovarian cancer. Obstet Gynecol (2013) 122:1025-32. doi:10.1097/AOG.0b013e3182a92011
54. Bristow RE, Zahurak ML, Ibeanu OA. Racial disparities in ovarian cancer surgical care: a population-based analysis. Gynecol Oncol (2011) 121:364-8. doi:10.1016/j.ygyno.2010.12.347
55. Wright J, Doan T, McBride R, Jacobson J, Hershman D. Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival. Br J Cancer (2008) 98:1197-203. doi:10.1038/sj.bjc.6604298
56. Winter WE III, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol (2007) 25:3621-7. doi:10.1200/JCO.2006.10.2517
57. Farley JH, Tian C, Rose GS, Brown CL, Birrer M, Maxwell GL. Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials. Cancer (2009) 115:4210-7. doi:10.1002/cncr.24482
58. Terplan M, Schluterman N, McNamara EJ, Tracy JK, Temkin SM. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol (2012) 125:19-24. doi:10.1016/j.ygyno.2011.11.025
59. Allard JE, Maxwell GL. Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer. Cancer Control (2009) 16:53-6
60. Yap OWS, Matthews RP. Racial and ethnic disparities in cancers of the uterine corpus. J Natl Med Assoc (2006) 98:1930-3
61. Rodriguez AM, Schmeler KM, Kuo Y-F. Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women. Gynecol Oncol (2014) 135:525-33. doi:10.1016/j.ygyno.2014.10.021
62. Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health (2004) 94:2104-11. doi:10.2105/AJPH.94.12.2104
63. Kost ER, Hall KL, Hines JF, Farley JH, Nycum LR, Rose GS, et al. Asian-Pacific Islander race independently predicts poor outcome in patients with endometrial cancer. Gynecol Oncol (2003) 89:218-26. doi:10.1016/S0090-8258(03)00050-7
64. Wright JD, Fiorelli J, SchiffPB, Burke WM, Kansler AL, Cohen CJ, et al. Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time. Cancer (2009) 115:1276-85. doi:10.1002/cncr.24160
65. Long B, Liu FW, Bristow RE. Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States. Gynecol Oncol (2013) 130:652-9. doi:10.1016/j.ygyno.2013.05.020
66. Setiawan VW, Pike MC, Kolonel LN, Nomura AM, Goodman MT, Henderson BE. Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study. Am J Epidemiol (2007) 165:262-70. doi:10.1093/aje/kwk010
67. Sherman ME, Devesa SS. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer (2003) 98:176-86. doi:10.1002/cncr.11484
68. Smotkin D, Nevadunsky NS, Harris K, Einstein MH, Yu Y, Goldberg GL. Histopathologic differences account for racial disparity in uterine cancer survival. Gynecol Oncol (2012) 127:616-9. doi:10.1016/j.ygyno.2012.08.025
69. Maxwell GL, Tian C, Risinger J, Brown CL, Rose GS, Thigpen JT, et al. Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study. Cancer (2006) 107:2197-205. doi:10.1002/cncr.22232
70. Olson SH, Atoria CL, Cote ML, Cook LS, Rastogi R, Soslow RA, et al. The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol Biomarkers Prev (2012) 21:753-60. doi:10.1158/1055-9965.EPI-11-0735
71. Hicks ML, Phillips JL, Parham G, Andrews N, Jones WB, Shingleton HM, et al. The National Cancer Data Base report on endometrial carcinoma in African-American women. Cancer (1998) 83:2629-37. doi:10.1002/(SICI)1097-0142(19981215)83:12<2629::AID-CNCR30>3.0.CO;2-2
72. Randall TC, Armstrong K. Differences in treatment and outcome between African-American and white women with endometrial cancer. J Clin Oncol (2003) 21:4200-6. doi:10.1200/JCO.2003.01.218
73. Rauh-Hain JA, Buskwofie A, Clemmer J, Boruta DM, Schorge JO, del Carmen MG. Racial disparities in treatment of high-grade endometrial cancer in the Medicare population. Obstet Gynecol (2015) 125:843-51. doi:10.1097/AOG.0000000000000605
74. Armstrong K, Randall TC, Polsky D, Moye E, Silber JH. Racial differences in surgeons and hospitals for endometrial cancer treatment. Med Care (2011) 49:207-14. doi:10.1097/MLR.0b013e3182019123
75. Maxwell GL, Tian C, Risinger JI, Hamilton CA, Barakat RR, Gynecologic Oncology Group Study. Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy? Cancer (2008) 113:1431-7. doi:10.1002/cncr.23717
76. Kohler MF, Berchuck A, DavidoffAM, Humphrey PA, Dodge RK, Iglehart JD, et al. Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res (1992) 52:1622-7
77. Clifford SL, Kaminetsky CP, Cirisano FD, Dodge R, Soper JT, Clarke-Pearson DL, et al. Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer. Am J Obstet Gynecol (1997) 176:S229-32. doi:10.1016/S0002-9378(97)70380-6
78. Santin AD, Bellone S, Siegel ER, Palmieri M, Thomas M, Cannon MJ, et al. Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer. Am J Obstet Gynecol (2005) 192:813-8. doi:10.1016/j.ajog.2004.10.605
79. Maxwell GL, Risinger JI, Hayes KA, Alvarez AA, Dodge RK, Barrett JC, et al. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers. Clin Cancer Res (2000) 6:2999-3005
80. Harper S, Lynch J. Methods for Measuring Cancer Disparities: Using Data Relevant to Healthy People 2010 Cancer-Related Objectives. NCI Cancer Surveillance Monograph Series, Number 6. Bethesda, MD: National Cancer Institute (2005). NIH Publication No. 05-5777. Available from: http://www.cancer.gov/about-nci/organization/crchd/cancer-health-disparities-fact-sheet
81. Niccolai LM, Mehta NR, Hadler JL. Racial/Ethnic and poverty disparities in human papillomavirus vaccination completion. Am J Prev Med (2011) 41:428-33. doi:10.1016/j.amepre.2011.06.032
82. Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics (2011) 127:77-84. doi:10.1542/peds.2010-0812
83. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13-17 years-United States, 2011. MMWR Morb Mortal Wkly Rep (2012) 61:671-7
84. Centers for Disease Control and Prevention (CDC). Cancer screening-United States, 2010. MMWR Morb Mortal Wkly Rep (2012) 61:41-5
85. Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W. Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol (2005) 105:1323-8. doi:10.1097/01.AOG.0000159549.56601.75
86. Del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E. Ethnic differences in patterns of care of stage 1A(1) and stage 1A(2) cervical cancer: a SEER database study. Gynecol Oncol (1999) 75:113-7. doi:10.1006/gyno.1999.5543
87. Mundt AJ, Connell PP, Campbell T, Hwang JH, Rotmensch J, Waggoner S. Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol (1998) 71:151-8. doi:10.1006/gyno.1998.5203
88. Farley JH, Hines JF, Taylor RR, Carlson JW, Parker MF, Kost ER, et al. Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer (2001) 91:869-73. doi:10.1002/1097-0142(20010215)91:4<869::AID-CNCR1075>3.3.CO;2-4